Monday, August 17, 2026
23
C
Bengaluru
Hot topics
Why Most AI Healthcare Tools Stall at the Pilot Stage
Artificial intelligence (AI) in healthcare consistently demonstrates remarkable technical...
A Cardiologist Recounts his Fightback from a Near Death Covid19 Infection
In the lockdown, while I was on regular OPD and ICU rounds at a COVID hospital, I started noticing some mild symptoms of the Coronavirus infection. Being in the medical field and considering the severity of the pandemic situation then, I was very careful and cautious, and observed the symptoms closely. The symptoms persisted and I had to self-quarantine until the medical test reports came. It was important for me to isolate myself from the rest of the medical team and prevent the spread of the virus. Finally, the report came: I was COVID positive!
Stunned and slightly devastated; I broke the news to my family who could not believe it either. As a doctor, I could only treat, comfort and empathize with the COVID patients undergoing treatment; completely isolated from their loved ones. But now, I could actually feel the uncertainty of the situation. I was hospitalized and continued to experience body-ache during the admission. It was a stressful situation where I felt anxious and stressed about everything.
My CT scan reports showed mild lung infection on the day of admission but as the cytokines storm developed, my lungs were 76 % damaged in 3-5 days and I was short of breath and my oxygen level deteriorated to less than 80. I was shifted to an ICU with high-flow oxygen and was on a BiPap machine which I had purchased a few weeks ago for the hospital and never imagined that I would be using myself one day.
DeepSeek – A Precursor to Patent Disruption?
The rise of open-source platforms, such as China’s DeepSeek...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Hot topics
Medical Rep to Doctorate in Human Resources and Board of Directors
MVS Murthy
I began my career as a Medical Rep...
Biocon Biologics Scores FDA Approval—A Biosimilar Shake-Up for Amgen, Patients, and Investors
Biocon Biologics secures FDA approval for Bosaya™ and Aukelso™,...
Are Indian Pharma Business Leaders Adopting Digital Transformation?
We will need to find a way to bring together the capabilities of the Medical Rep, the changed scenario of the visit and the ways we can reach doctors into one single strategy rather than looking at the physical and the digital parts separately. Our medical reps will continue to be the core of our promotion, and our digital strategy will need to empower them to not only do a better call but also support their efforts by building processes that will help them beyond the few minutes that they spend in the Clinic. Marketing budgets will have to move away from conventional investments and also think beyond hardware to increase digital engagement.
India’s Booming OTC Pain Management Market: Trends, Growth & Consumer Behaviors
India’s Booming Pain Management Market: Trends, Growth & Consumer...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Newsletter
Get important news delivered directly to your inbox and stay connected!